NO20060676L - Parasittisidiske sammensetninger - Google Patents

Parasittisidiske sammensetninger

Info

Publication number
NO20060676L
NO20060676L NO20060676A NO20060676A NO20060676L NO 20060676 L NO20060676 L NO 20060676L NO 20060676 A NO20060676 A NO 20060676A NO 20060676 A NO20060676 A NO 20060676A NO 20060676 L NO20060676 L NO 20060676L
Authority
NO
Norway
Prior art keywords
closantel
salisyl
bioavailability
acid compositions
antiparasitic
Prior art date
Application number
NO20060676A
Other languages
English (en)
Other versions
NO336181B1 (no
Inventor
William Blakely
Lillian Cromie
Original Assignee
Norbrook Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norbrook Lab Ltd filed Critical Norbrook Lab Ltd
Publication of NO20060676L publication Critical patent/NO20060676L/no
Publication of NO336181B1 publication Critical patent/NO336181B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/36—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids
    • A01N37/38—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids having at least one oxygen or sulfur atom attached to an aromatic ring system
    • A01N37/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids having at least one oxygen or sulfur atom attached to an aromatic ring system having at least one carboxylic group or a thio analogue, or a derivative thereof, and one oxygen or sulfur atom attached to the same aromatic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/609—Amides, e.g. salicylamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pest Control & Pesticides (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Toxicology (AREA)
  • Road Paving Structures (AREA)

Abstract

En antiparasittisidisk sammensetning presentert som et topisk "flytende" produkt for å behandle dyr infisert av parasitter som er kjent for å være følsomme for salisylanihder, spesielt closantel, alene eUer sammen med minst en annen antiparasittisk forbindelse av avermectin eller milbemycintype og gir fremmet biotilgjengehghet av salisylanilidet ved fremskaffelse av et avleveringssystem omfattende minst 20 % (v/v) av en eUer flere alkoholer og som eventuelt inkluderer en polymerenhet valgt fra gruppen bestående av polyvinylpyrrohdon (PVP), polyoksypropylen/polyoksyetylen blokk-kopolymerer (poloksamer) og polyetylenglykoler (PEG), derved bedres biotUgjengeligheten tU for eksempel closantel (som anslått når det gjelder closantels blodplasmanivåer).
NO20060676A 2003-07-12 2006-02-10 Antiparasittiske flytende sammensetninger med salisylanilid og transdermalt avleveringssystem NO336181B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0316377.1A GB0316377D0 (en) 2003-07-12 2003-07-12 Parasiticidal composition
PCT/GB2004/003006 WO2005007241A1 (en) 2003-07-12 2004-07-12 Parasiticidal composition

Publications (2)

Publication Number Publication Date
NO20060676L true NO20060676L (no) 2006-02-10
NO336181B1 NO336181B1 (no) 2015-06-08

Family

ID=27742085

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060676A NO336181B1 (no) 2003-07-12 2006-02-10 Antiparasittiske flytende sammensetninger med salisylanilid og transdermalt avleveringssystem

Country Status (28)

Country Link
US (1) US8993546B2 (no)
EP (2) EP1646425B1 (no)
JP (1) JP4677405B2 (no)
KR (1) KR101095419B1 (no)
CN (1) CN1822880B (no)
AP (1) AP2956A (no)
AU (1) AU2004257450B2 (no)
BR (1) BRPI0412522A (no)
CA (1) CA2532199C (no)
CR (1) CR8174A (no)
DK (1) DK1646425T3 (no)
EA (1) EA009602B1 (no)
EC (1) ECSP066360A (no)
ES (1) ES2390224T3 (no)
GB (2) GB0316377D0 (no)
GE (1) GEP20094648B (no)
HR (1) HRP20120721T1 (no)
IL (1) IL173057A (no)
MX (1) MXPA06000135A (no)
NO (1) NO336181B1 (no)
NZ (1) NZ544973A (no)
OA (1) OA13188A (no)
PL (1) PL1646425T3 (no)
PT (1) PT1646425E (no)
SI (1) SI1646425T1 (no)
TN (1) TNSN06006A1 (no)
WO (1) WO2005007241A1 (no)
ZA (1) ZA200600374B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002952597A0 (en) * 2002-11-11 2002-11-28 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
GB0501220D0 (en) * 2005-01-21 2005-03-02 Norbrook Lab Ltd Anthelmintic composition
GB0711957D0 (en) * 2007-06-21 2007-08-01 Syntopix Ltd Formulations
CN101693009B (zh) * 2009-10-27 2010-12-01 纽素乐必佳（天津）药业集团有限公司 牛羊用抗寄生虫病氯氰碘柳胺钠透皮溶液及其制备方法
FR2991173B1 (fr) 2012-06-04 2015-11-06 Virbac Composition veterinaire a administration cutanee a base d'oxyclozanide
CN103720652B (zh) * 2014-01-07 2016-09-28 王玉万 用泊洛沙姆和油性介质制备含阿维菌素类药物注射剂
WO2019054967A2 (en) * 2017-03-15 2019-03-21 Verano Ilac Sanayi Ve Ticaret Anonim Sirketi VETERINARY COMPOSITION TO BE POURED COMPRISING EPRINOMECTIN
GB201715122D0 (en) * 2017-09-19 2017-11-01 Omnipharm Dev Ltd Topical anti-infective formulation
US20230165798A1 (en) * 2018-10-12 2023-06-01 Hovione Scientia Macrocyclic lactone formulations, methods of their preparation and use of the formulations in treating pathologies secondary to ophthalmic parasites

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2731386A (en) * 1951-09-06 1956-01-17 Wallace & Tiernan Company Inc Antifungal composition
US3798258A (en) * 1970-03-13 1974-03-19 Merck & Co Inc Salicylanilides
LU62350A1 (no) * 1970-12-31 1972-08-23
US3950360A (en) 1972-06-08 1976-04-13 Sankyo Company Limited Antibiotic substances
US4005218A (en) 1975-03-18 1977-01-25 Janssen Pharmaceutica N.V. Antiparasitic salicylanilide derivatives
SE434277B (sv) 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4206205A (en) 1977-10-03 1980-06-03 Merck & Co., Inc. Monosaccharide and aglycone derivatives of C-076
US4199569A (en) 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US4201861A (en) 1977-10-03 1980-05-06 Merck & Co., Inc. Acyl derivatives of C-076 compounds
US4171314A (en) 1977-12-19 1979-10-16 Merck & Co., Inc. 13-Halo and 13-deoxy C-076 compounds
US4173571A (en) 1977-12-19 1979-11-06 Merck & Co., Inc. 13-Halo and 13-deoxy derivatives of C-076 compounds
NZ197796A (en) 1980-08-04 1984-11-09 Merck & Co Inc Stabilised aqueous formulations containing ivermectin
NZ210505A (en) 1983-12-22 1988-06-30 Merck & Co Inc Parasiticidal compositions containing avermectin or milbemycin derivatives
NZ335166A (en) 1999-04-14 2001-11-30 Ashmont Holdings Ltd Anthelmintic composition containing triclabendazole in at least one solvent
RU2033150C1 (ru) 1992-06-10 1995-04-20 Виктор Антонович Дриняев Препарат для лечения и профилактики псороптоза у животных "аверсект"
PL174488B1 (pl) * 1993-05-10 1998-08-31 Merck & Co Inc Preparat do zwalczania pasożytów zwierząt oraz sposób wytwarzania preparatu do zwalczania pasożytów zwierząt
ES2170099T3 (es) * 1993-05-26 2002-08-01 Commw Scient Ind Res Org Composiciones antiparasitarias.
DE69432985D1 (de) 1993-06-15 2003-09-04 Australian Nat University Acto Synergistische anthelmintische zusammensetzungen gegen fasciola hepatica und andere fascola spezien
NZ248486A (en) * 1993-08-24 1996-07-26 Ashmont Holdings Limited Subst Stable anthelmintic formulation containing closantel and one or more avermectins or milbemycins in a glycol based solvent
FR2739778B1 (fr) * 1995-10-13 1997-12-12 Virbac Lab Formulation topique destinee a traiter la maladie de la douve du foie chez l'animal
RU2112508C1 (ru) 1995-12-26 1998-06-10 Писков Вячеслав Борисович Способ лечения и профилактики саркоптоидозов животных
RU2121831C1 (ru) 1997-08-01 1998-11-20 Анатолий Александрович Непоклонов Препарат для профилактики и лечения гиподерматоза крупного рогатого скота
AUPP105497A0 (en) * 1997-12-19 1998-01-15 Schering-Plough Animal Health Limited Aqueous insecticidal pour-on treatment
RU2129430C1 (ru) 1998-03-17 1999-04-27 Общество С Ограниченной Ответственностью "Вик - Здоровье Животных" Препарат для борьбы с экто- и эндопаразитами животных "сантомектин"
US6239119B1 (en) * 1998-04-27 2001-05-29 Medimmune Oncology, Inc. Topical administration of amifostine and related compounds
GB9816132D0 (en) * 1998-07-24 1998-09-23 Norbrook Lab Ltd Non-aqueous anthelmintic composition
GEP20012490B (en) 1999-10-21 2001-07-25 Robizon Bostashvili Means Against Demodicosis of Agricultural and Domestic Animals
US6340672B1 (en) * 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation
US6399651B1 (en) * 2000-06-29 2002-06-04 L. Dean Parks Method of treating dermatoses using avermectin compound
AUPQ875700A0 (en) * 2000-07-13 2000-08-03 Reflex Research Limited Combination compositions
CA2449103A1 (en) * 2001-06-01 2002-12-12 Tendskin Company Topical compositions for veterinary uses
GB2386067A (en) * 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising an avermectin or milbemycin, plus a salicylanilide & a polymeric species
AU2002952597A0 (en) * 2002-11-11 2002-11-28 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
AU2003275779B2 (en) * 2002-11-11 2009-02-05 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
AU2003900505A0 (en) * 2003-02-05 2003-02-20 Jurox Pty Ltd Anthelmintic composition

Also Published As

Publication number Publication date
CA2532199A1 (en) 2005-01-27
NO336181B1 (no) 2015-06-08
OA13188A (en) 2006-12-13
US20060142216A1 (en) 2006-06-29
GB2403905A (en) 2005-01-19
GEP20094648B (en) 2009-03-25
ZA200600374B (en) 2007-05-30
EP1646425B1 (en) 2012-08-22
GB0316377D0 (en) 2003-08-13
EA009602B1 (ru) 2008-02-28
GB0415541D0 (en) 2004-08-11
WO2005007241A1 (en) 2005-01-27
IL173057A0 (en) 2006-06-11
EP1646425A1 (en) 2006-04-19
NZ544973A (en) 2008-09-26
JP4677405B2 (ja) 2011-04-27
TNSN06006A1 (en) 2007-10-03
SI1646425T1 (sl) 2012-12-31
CN1822880B (zh) 2012-07-11
EA200600237A1 (ru) 2006-06-30
DK1646425T3 (da) 2012-09-17
AU2004257450A1 (en) 2005-01-27
AP2956A (en) 2014-08-31
AU2004257450B2 (en) 2008-08-28
GB2403905B (en) 2005-12-14
HK1096621A1 (en) 2007-06-08
KR101095419B1 (ko) 2011-12-16
MXPA06000135A (es) 2006-04-07
PL1646425T3 (pl) 2013-01-31
US8993546B2 (en) 2015-03-31
CA2532199C (en) 2012-05-15
BRPI0412522A (pt) 2006-09-19
EP2286876A1 (en) 2011-02-23
ES2390224T3 (es) 2012-11-07
JP2007528866A (ja) 2007-10-18
HRP20120721T1 (hr) 2012-10-31
WO2005007241A8 (en) 2005-03-10
AP2006003506A0 (en) 2006-02-28
ECSP066360A (es) 2006-10-31
IL173057A (en) 2013-10-31
KR20060113631A (ko) 2006-11-02
PT1646425E (pt) 2012-10-31
CN1822880A (zh) 2006-08-23
CR8174A (es) 2006-10-05

Similar Documents

Publication Publication Date Title
Beshbishy et al. Ellagic acid microspheres restrict the growth of Babesia and Theileria in vitro and Babesia microti in vivo
CA2476520A1 (en) Long acting parasiticidal composition containing a salicylanilide compound, a polymeric species and at least one other anti-parasitic compound
NO20060676L (no) Parasittisidiske sammensetninger
KR20080090489A (ko) 살균제 조성물 및 그 사용 방법
NO20010531L (no) Medisinske aerosolformuleringer
WO2002081453A8 (fr) Hiohydantoïnes et leur utilisation dans le traitement du diabete
EP2648703A1 (en) Pharmaceutical composition comprising trans-cinnamaldehyde and its use in the treatment of infections
TR200606411T1 (tr) Vajinite karşı bir triazol içeren bileşimler.
AU2023201883B2 (en) Anti-virus agent and method for treatment of viral infection
US9474723B2 (en) Anti-microbial composition
Cauvin et al. The impact of vector control on the prevalence of Theileria cervi in farmed Florida white-tailed deer, Odocoileus virginianus
Hejrati et al. Association of coronavirus pathogencity with the level of antioxidants and immune system
Gu et al. Novel virostatic agents against bluetongue virus
US10668043B2 (en) Potentiated antimicrobial agents
EP3220923B1 (en) Copolymer and method for treatment of bacterial infection
Vanachayangkul et al. Safety, pharmacokinetics, and liver-stage Plasmodium cynomolgi effect of high-dose ivermectin and chloroquine in Rhesus Macaques
NO20081754L (no) Anthelmintiske formuleringer
Bifano et al. Daclatasvir Pharmacokinetics in Healthy Subjects: No Clinically-Relevant Drug-Drug Interactions with Either Cyclosporine or Tacrolimus: 1081
NO20080420L (no) Formulering med forlenget frigivelse av aktive bestanddeler med pH-avhengig loselighet
RU2805806C1 (ru) Способ профилактики респираторных вирусных инфекций (гриппа)
Kory et al. Retraction notice
US10758620B2 (en) Potentiated antimicrobial agents
EP1464636A4 (en) NEW SUBSTANCE WITH ANTITUM EFFECT / INFLAMMATORY EFFECT
Åstrand et al. Dapagliflozin‐lowered blood glucose reduces respiratory P. aeruginosa infection in diabetic mice
Seed et al. The Classic Paper of Tobie, Von brand, and Mehlman (1950) REVISITED

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees